Global miRNA Sequencing and Assay Market

miRNA Sequencing and Assay Market is expected to reach US$ 702.29 Mn. at a CAGR of 13% during the forecast period 2029.

The Global miRNA Sequencing and Assay Market report is a comprehensive analysis of the industry, market, and key players. The report has covered the market by demand and supply-side by segments. The Global miRNA Sequencing and Assay Market report also provides trends by market segments, Product, and investment with a competitive landscape.

miRNA Sequencing and Assay Market Overview.

miRNA is a family of small ribonucleic acid, with 21-25 nucleotides in a length. And this controls protein expression through transcript degradation, inhibition of translation. miRNA are now involved in the regulation of many developments and biological processes like hematopoiesis, lipid metabolism, and neuronal development.To know about the Research Methodology :- Request Free Sample Report

miRNA Sequencing and Assay Market Dynamics:

The Global miRNA Sequencing and Assay Market was valued at USD 298.51 million in 2022 and is estimated to reach 702.29 million with a growing CAGR of 13% in the forecast period of 2023-2029.

There are various benefits of miRNA like sequence independence, coverage coupled with disadvantages like high cost, infrastructure requirements, run length, and potential artifacts. The miRNA is a type of RNA sequence, uses next-generation sequencing. miRNA is different from RNA sequence and plays important role in diseases like cancer. The development in technology in nucleotide sequencing is likely to fuel the market growth in the forecast period.

miRNA is a chief biomarker in various diseases like cancer, as their deregulation is responsible to cause malignancy and tumor formation. Further, increasing the application of miRNA is likely to increase the investment in the market. Moreover, the growth of the market is primarily driven by factors like advantages like miRNA sequencing over other technologies, rising research funding for genomics, and the decreasing cost of sequencing.

Further, this process of RNA sequencing is highly carried out by skilled profession as this process is carried out in a highly intimate environment to avoid contamination. And lack of skilled professionals is likely to hamper the market growth in the coming future.

miRNA Sequencing and Assay Market Segment Analysis:

Library preparation is anticipated to adhere to the growth of the product segment of the MiRNA Sequencing and Assay Market.

Library preparation is governing the growth of the product segment with the highest CAGR of 13.58% in the forecast period. The techniques like Nest-Generation Sequencing (NGS) technique for miRNA analysis is fueling the market growth in the forecast period. Moreover, Nest-Generation Sequencing (NGS) technique offers various benefits like higher sensitivity to detect low-frequency variants, the faster turnaround time for high sample volumes, comprehensive genomic coverage, the lower limit of detection, higher throughput with sample multiplexing, ability to sequencing hundreds to thousands of genes or gene regions simultaneously. Due to these benefits, the NGS technique is highly preferred in library preparation and this is estimated to motivate the growth in the forecast period.

Consumables are dominating in the product segment due to the wider adoption of small RNA sequencing and the sequencing the consumables segment is marked the highest market share of 58.9% in the year 2022.

Sequencing by Synthesis technology is supplementing the growth of the miRNA Sequencing and Assay Market.

Sequencing by synthesis technology is holding a prominent market share in the miRNA Sequencing and Assay Market and accounted for the largest revenue share of 33.4% in 2022. The growth of the sequencing by synthesis technology segment is attributed to research studies carried out on sequencing of miRNA and assay by synthesis. As per the research carried out in Germany, China, the US evaluated that sequencing by synthesis (SBS) recovers more interpreted miRNA, and generated more novel miRNAs. Moreover, this technology is used in the study of several cancers. And this factor is estimated to boost the market growth in the forecast period.

Research Institutes is Trending in End-User Segment of miRNA Sequencing and Assay Market.

Research Institutes is dominating the end-user segment of the miRNA sequencing and assay market and the segment accounts for the largest revenue share of 56.6% in 2022. This growth is estimated due to several initiatives on research studies and the sequencing of miRNA. Moreover, the studies carried out on product development, novel drug delivery, and clinical research is boosting the market of miRNA sequencing and assay. Moreover, miRNA has various applications in cancer, Polyglutamine Diseases, Autoimmune Disease, Schizophrenia, and various others. Further, the pharmaceutical industry is expected to grow with the highest CAGR in the forecast period. Due to rising investments in R & D and biotechnology in the development of miRNA-based therapeutics is likely to boost the market growth in the forecast period.

Regional Insights:

North America holds the dominating share in the market owing to the presence of prominent market players in the region like Thermo fisher scientific PerkinElmer, Inc., and others. Moreover, the investment by the government in research and development by dominating players for the innovation of advanced therapeutics, and pharmaceutical medicines is likely to fuel the market growth in the regional segment. Further, Illumina, Inc. invested USD 682 million in the R&D sector for the development of new sequence analysis technology with high-end features. Moreover, miRNA sequencing is highly used in the region and implemented by various healthcare and defense sectors like clinics, military, agriculture labs. And this adoption is stimulating the growth of the miRNA Sequencing and Assay market.

The Asia Pacific is estimated to grow at a significant pace due to growing genetic research activities carried out in the region. As the region is growing with developing economies and modernization this factor is likely to motivate market growth. Moreover, China is gaining more attention in the Asia Pacific market owing to rapid advancement in technology and the chemical industry. Further, the biotechnology market of china is growing with a CAGR of 7.8% in the forecast period.

The objective of the report is to present a comprehensive analysis of the Global miRNA Sequencing and Assay Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding the Global miRNA Sequencing and Assay Market dynamics, structure by analyzing the market segments and project the Global miRNA Sequencing and Assay Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Global miRNA Sequencing and Assay Market make the report investor’s guide.

miRNA Sequencing and Assay Market Scope: Inquire before buying

by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

miRNA Sequencing and Assay Market Key Players

1. Illumina Inc.
2. Thermo Fisher Scientific Inc.
3. Qiagen N.V.
4. Takara Bio Inc.
5. New England Biolabs, Inc.
6. Perkinelmer, Inc.
7. Norgen Biotek Corporation
8. Trilink Biotechnologies
9. Lexogen
10.Oxford Nanopore Technologies
11.F. Hoffmann-La Roche Ltd.
12.Bio-Rad Laboratories Inc.
13.Sigma Aldrich Corp.
14.HTG Molecular Diagnostics, Inc.
15.Rosetta Genomics Ltd.
16.Kaneka Corporation
17.Abcam PLC.
18.Meridian Bioscience, Inc
19.System Biosciences LLC

Frequently Asked Questions:

1. Which region has the largest share in Global MiRNA Sequencing and Assay Market?
Ans: North America region held the highest share in 2022.

2. What is the growth rate of Global MiRNA Sequencing and Assay Market?
Ans: The Global MiRNA Sequencing and Assay Market is growing at a CAGR of 13% during forecasting period 2023-2029.

3. What is scope of the Global MiRNA Sequencing and Assay market report?
Ans: Global market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global MiRNA Sequencing and Assay market?
Ans: The important key players in the Global MiRNA Sequencing and Assay Market are – Illumina Inc., Thermo Fisher Scientific Inc., Qiagen N.V., Takara Bio Inc., New England Biolabs, Inc., Perkinelmer, Inc., Norgen Biotek Corporation, Trilink Biotechnologies, Lexogen, Oxford Nanopore Technologies, F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories Inc., Sigma Aldrich Corp., HTG Molecular Diagnostics, Inc., Rosetta Genomics Ltd., Kaneka Corporation, Abcam PLC., Meridian Bioscience, Inc, and System Biosciences LLC

5. What is the study period of this market?
Ans: The Global MiRNA Sequencing and Assay Market is studied from 2022 to 2029.